目次

Table of contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Drug Discovery Outsourcing Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary
2.1 Global Trade: Taxes & Tariffs

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Reduced Pharmaceutical and Biotech R&D Budgets
3.3.1.2 Emerging Markets are a Popular Destination for CROs
3.3.1.3 Improving Conditions in the Industry will Drive Healthy Growth
3.3.1.4 Cost Reduction: A Central Driver for Outsourcing
3.3.1.5 Accelerating the Discovery of Drug Candidates
3.3.2 Market Restraining Factors
3.3.2.1 Limited IP Protection
3.3.2.2 Threat of Private Public Alliances
3.3.3 Market Opportunities
3.3.3.1 Strategic Partnerships to Offer Lucrative Growth Prospects
3.3.3.2 Investment in Artificial Intelligence to Offer Fresh Revenue Pockets
3.3.3.3 Available Scope for the Expansion of CROs
3.3.3.4 Targeted Therapies: Advances in Biologics and Orphan Drugs
3.4 R&D Outsourcing Business Model (Fee-for-Service)
3.5 Collaborations Between CRO and Pharmaceutical Industry
3.6 Porter’s Five Forces Analysis
3.6.1 Competitive Rivalry: High
3.6.2 Threat of Substitutes: Medium
3.6.3 Bargaining Power of Buyer: High
3.6.4 Bargaining Power of Suppliers: Medium
3.6.5 Threat of New Entrants: Medium

4 Drug Discovery Outsourcing Market Analysis by Service Type
4.1 Key Findings
4.2 Service Type Segment: Market Attractiveness Index
4.3 Drug Discovery Outsourcing Market Size Estimation and Forecast by Service Type
4.4 Chemistry Services
4.4.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
4.4.2 Market Share by Region, 2025 & 2035 (%)
4.5 Biology Services
4.5.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
4.5.2 Market Share by Region, 2025 & 2035 (%)

5 Drug Discovery Outsourcing Market Analysis by Workflow
5.1 Key Findings
5.2 Workflow Segment: Market Attractiveness Index
5.3 Drug Discovery Outsourcing Market Size Estimation and Forecast by Workflow
5.4 Target Identification & Screening
5.4.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
5.4.2 Market Share by Region, 2025 & 2035 (%)
5.5 Target Validation & Functional Informatics
5.5.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
5.5.2 Market Share by Region, 2025 & 2035 (%)
5.6 Lead Identification & Candidate Optimization
5.6.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
5.6.2 Market Share by Region, 2025 & 2035 (%)
5.7 Preclinical Development
5.7.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
5.7.2 Market Share by Region, 2025 & 2035 (%)
5.8 Other Associated Workflow
5.8.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
5.8.2 Market Share by Region, 2025 & 2035 (%)

6 Drug Discovery Outsourcing Market Analysis by Therapeutic Area
6.1 Key Findings
6.2 Therapeutic Area Segment: Market Attractiveness Index
6.3 Drug Discovery Outsourcing Market Size Estimation and Forecast by Therapeutic Area
6.4 Oncology
6.4.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
6.4.2 Market Share by Region, 2025 & 2035 (%)
6.5 Infectious Disease
6.5.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
6.5.2 Market Share by Region, 2025 & 2035 (%)
6.6 Central Nervous System
6.6.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
6.6.2 Market Share by Region, 2025 & 2035 (%)
6.7 Immunology
6.7.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
6.7.2 Market Share by Region, 2025 & 2035 (%)
6.8 Cardiovascular Disease
6.8.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
6.8.2 Market Share by Region, 2025 & 2035 (%)
6.9 Metabolic Disease
6.9.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
6.9.2 Market Share by Region, 2025 & 2035 (%)
6.10 Respiratory Disease
6.10.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
6.10.2 Market Share by Region, 2025 & 2035 (%)
6.11 Others
6.11.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
6.11.2 Market Share by Region, 2025 & 2035 (%)

7 Drug Discovery Outsourcing Market Analysis by Molecule Type
7.1 Key Findings
7.2 Molecule Type Segment: Market Attractiveness Index
7.3 Drug Discovery Outsourcing Market Size Estimation and Forecast by Molecule Type
7.4 Large Molecules
7.4.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
7.4.2 Market Share by Region, 2025 & 2035 (%)
7.5 Small Molecules
7.5.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
7.5.2 Market Share by Region, 2025 & 2035 (%)

8 Drug Discovery Outsourcing Market Analysis by End-users
8.1 Key Findings
8.2 End-users Segment: Market Attractiveness Index
8.3 Drug Discovery Outsourcing Market Size Estimation and Forecast by End-users
8.4 Pharmaceutical & Biotechnology Companies
8.4.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
8.4.2 Market Share by Region, 2025 & 2035 (%)
8.5 Academic Institutes
8.5.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
8.5.2 Market Share by Region, 2025 & 2035 (%)
8.6 Others
8.6.1 Market Forecast by Region, 2025-2035 (US$ Mn, AGR %)
8.6.2 Market Share by Region, 2025 & 2035 (%)

9 Drug Discovery Outsourcing Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast

10 North America Drug Discovery Outsourcing Market Analysis
10.1 Key Findings
10.2 North America Drug Discovery Outsourcing Market Attractiveness Index
10.3 Market Size by Country, 2025, 2030 & 2035 (US$ Mn)
10.4 Market Size Estimation and Forecast by Country, 2025-2035 (US$ Mn)
10.5 Market Size Estimation and Forecast by Service Type, 2025-2035 (US$ Mn)
10.6 Market Size Estimation and Forecast by Workflow, 2025-2035 (US$ Mn)
10.7 Market Size Estimation and Forecast by Therapeutic Area, 2025-2035 (US$ Mn)
10.8 Market Size Estimation and Forecast by Molecule Type, 2025-2035 (US$ Mn)
10.9 Market Size Estimation and Forecast by End-users, 2025-2035 (US$ Mn)
10.10 U.S. Drug Discovery Outsourcing Market Analysis
10.11 Canada Drug Discovery Outsourcing Market Analysis

11 Europe Drug Discovery Outsourcing Market Analysis
11.1 Key Findings
11.2 Europe Drug Discovery Outsourcing Market Attractiveness Index
11.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Market Size Estimation and Forecast by Country, 2025-2035 (US$ Mn)
11.5 Market Size Estimation and Forecast by Service Type, 2025-2035 (US$ Mn)
11.6 Market Size Estimation and Forecast by Workflow, 2025-2035 (US$ Mn)
11.7 Market Size Estimation and Forecast by Therapeutic Area, 2025-2035 (US$ Mn)
11.8 Market Size Estimation and Forecast by Molecule Type, 2025-2035 (US$ Mn)
11.9 Market Size Estimation and Forecast by End-users, 2025-2035 (US$ Mn)
11.10 Germany Drug Discovery Outsourcing Market Analysis
11.11 UK Drug Discovery Outsourcing Market Analysis
11.12 France Drug Discovery Outsourcing Market Analysis
11.13 Italy Drug Discovery Outsourcing Market Analysis
11.14 Spain Drug Discovery Outsourcing Market Analysis
11.15 Russia Drug Discovery Outsourcing Market Analysis
11.16 Rest of Europe Drug Discovery Outsourcing Market Analysis

12 Asia Pacific Drug Discovery Outsourcing Market Analysis
12.1 Key Findings
12.2 Asia Pacific Drug Discovery Outsourcing Market Attractiveness Index
12.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 Market Size Estimation and Forecast by Country, 2025-2035 (US$ Mn)
12.5 Market Size Estimation and Forecast by Service Type, 2025-2035 (US$ Mn)
12.6 Market Size Estimation and Forecast by Workflow, 2025-2035 (US$ Mn)
12.7 Market Size Estimation and Forecast by Therapeutic Area, 2025-2035 (US$ Mn)
12.8 Market Size Estimation and Forecast by Molecule Type, 2025-2035 (US$ Mn)
12.9 Market Size Estimation and Forecast by End-users, 2025-2035 (US$ Mn)
12.10 Japan Drug Discovery Outsourcing Market Analysis
12.11 China Drug Discovery Outsourcing Market Analysis
12.12 India Drug Discovery Outsourcing Market Analysis
12.13 Australia Drug Discovery Outsourcing Market Analysis
12.14 South Korea Drug Discovery Outsourcing Market Analysis
12.15 South-East Asia Drug Discovery Outsourcing Market Analysis
12.16 Rest of Asia Pacific Drug Discovery Outsourcing Market Analysis

13 Latin America Drug Discovery Outsourcing Market Analysis
13.1 Key Findings
13.2 Latin America Drug Discovery Outsourcing Market Attractiveness Index
13.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
13.4 Market Size Estimation and Forecast by Country, 2025-2035 (US$ Mn)
13.5 Market Size Estimation and Forecast by Service Type, 2025-2035 (US$ Mn)
13.6 Market Size Estimation and Forecast by Workflow, 2025-2035 (US$ Mn)
13.7 Market Size Estimation and Forecast by Therapeutic Area, 2025-2035 (US$ Mn)
13.8 Market Size Estimation and Forecast by Molecule Type, 2025-2035 (US$ Mn)
13.9 Market Size Estimation and Forecast by End-users, 2025-2035 (US$ Mn)
13.10 Brazil Drug Discovery Outsourcing Market Analysis
13.11 Mexico Drug Discovery Outsourcing Market Analysis
13.12 Argentina Drug Discovery Outsourcing Market Analysis
13.13 Colombia Drug Discovery Outsourcing Market Analysis
13.14 Rest of Latin America Drug Discovery Outsourcing Market Analysis

14 MEA Drug Discovery Outsourcing Market Analysis
14.1 Key Findings
14.2 MEA Drug Discovery Outsourcing Market Attractiveness Index
14.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
14.4 Market Size Estimation and Forecast by Country, 2025-2035 (US$ Mn)
14.5 Market Size Estimation and Forecast by Service Type, 2025-2035 (US$ Mn)
14.6 Market Size Estimation and Forecast by Workflow, 2025-2035 (US$ Mn)
14.7 Market Size Estimation and Forecast by Therapeutic Area, 2025-2035 (US$ Mn)
14.8 Market Size Estimation and Forecast by Molecule Type, 2025-2035 (US$ Mn)
14.9 Market Size Estimation and Forecast by End-users, 2025-2035 (US$ Mn)
14.10 GCC Drug Discovery Outsourcing Market Analysis
14.11 South Africa Drug Discovery Outsourcing Market Analysis
14.12 Rest of MEA Drug Discovery Outsourcing Market Analysis

15 Company Profiles
15.1 Curia Global, Inc.
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Service Benchmarking
15.1.4 Strategic Outlook
15.2 Charles River Laboratories
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.3.1 Net Revenue, 2019-2024
15.2.3.2 Regional Market Shares, 2023
15.2.3.3 Business Segment Market Shares, 2023
15.2.4 Service Benchmarking
15.2.5 Strategic Outlook
15.3 Dalton Pharma
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Service Benchmarking
15.3.4 Strategic Outlook
15.4 Domainex
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Service Benchmarking
15.4.4 Strategic Outlook
15.5 Eurofins
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2019-2024
15.5.3.2 Regional Market Share, 2024
15.5.4 Service Benchmarking
15.5.5 Strategic Outlook
15.6 Evotec AG
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2019-2023
15.6.3.2 Regional Market Share, 2023
15.6.3.3 R&D, 2019-2023
15.6.4 Service Benchmarking
15.6.5 Strategic Outlook
15.7 Genscript
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Service Benchmarking
15.7.4 Strategic Outlook
15.8 Aragen Life Sciences Pvt. Ltd.
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Service Benchmarking
15.8.4 Strategic Outlook
15.9 Jubilant Biosys Ltd.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Service Benchmarking
15.10 Laboratory Corporation of America Holdings
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2019-2024
15.10.3.2 Business Segment Market Shares, 2023
15.10.4 Service Benchmarking
15.10.5 Strategic Outlook
15.11 Pharmaron
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2019-2023
15.11.4 Service Benchmarking
15.11.5 Strategic Outlook
15.12 QIAGEN N.V.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2019-2024
15.12.3.2 R&D, 2019-2024
15.12.4 Service Benchmarking
15.12.5 Strategic Outlook
15.13 Selvita
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Service Benchmarking
15.13.4 Strategic Outlook
15.14 BioDuro
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Service Benchmarking
15.15 Sygnature Discovery
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Service Benchmarking
15.15.4 Strategic Outlook
15.16 Syngene International
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Financial Analysis
15.16.3.1 Net Revenue, 2019-2024
15.16.3.2 Regional Market Share, 2024
15.16.4 Service Benchmarking
15.16.5 Strategic Outlook
15.17 Thermo Fisher Scientific Inc.
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Financial Analysis
15.17.3.1 Net Revenue, 2019-2024
15.17.3.2 R&D, 2019-2024
15.17.3.3 Regional Market Shares, 2023
15.17.3.4 Business Segment Market Shares, 2023
15.17.4 Service Benchmarking
15.17.5 Strategic Outlook
15.18 WuXi AppTec
15.18.1 Company Snapshot
15.18.2 Company Overview
15.18.3 Financial Analysis
15.18.3.1 Net Revenue, 2019-2024
15.18.3.2 Regional Market Shares, 2024
15.18.3.3 Business Segment Market Shares, 2024
15.18.4 Service Benchmarking
15.18.5 Strategic Outlook
15.19 Oncodesign
15.19.1 Company Snapshot
15.19.2 Company Overview
15.19.3 Service Benchmarking
15.19.4 Strategic Outlook
15.20 Novalix
15.20.1 Company Snapshot
15.20.2 Company Overview
15.20.3 Service Benchmarking
15.20.4 Strategic Outlook
15.21 Celonic Group
15.21.1 Company Snapshot
15.21.2 Company Overview
15.21.3 Service Benchmarking

16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players

List of Tables
Table 1 Drug Discovery Outsourcing Market Snapshot, 2025 & 2035 (US$ million, CAGR %)
Table 2 Drug Discovery Outsourcing Market Forecast by Service Type, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 3 Chemistry Services Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 4 Biology Services Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 5 Drug Discovery Outsourcing Market Forecast by Workflow, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 6 Target Identification & Screening Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 7 Target Validation & Functional Informatics Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 8 Lead Identification & Candidate Optimization Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 9 Preclinical Development Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 10 Other Associated Workflow Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 11 Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 12 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 13 Infectious Disease Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 14 Central Nervous System Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 15 Immunology Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 16 Cardiovascular Disease Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 17 Metabolic Disease Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 18 Respiratory Disease Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 19 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 20 Drug Discovery Outsourcing Market Forecast by Molecule Type, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 21 Large Molecules Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 22 Small Molecules Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 23 Drug Discovery Outsourcing Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 24 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 25 Academic Institutes Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 26 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 27 Global Drug Discovery Outsourcing Market Forecast by Region 2025-2035 (US$ Million, AGR%, CAGR%)
Table 28 North America Drug Discovery Outsourcing Market Forecast by Country, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 29 North America Drug Discovery Outsourcing Market Forecast by Service Type, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 30 North America Drug Discovery Outsourcing Market Forecast by Workflow, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 31 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 32 North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 33 North America Drug Discovery Outsourcing Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 34 U.S. Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 35 Canada Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 36 Europe Drug Discovery Outsourcing Market Forecast by Country, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 37 Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 38 Europe Drug Discovery Outsourcing Market Forecast by Workflow, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 39 Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 40 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 41 Europe Drug Discovery Outsourcing Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 42 Germany Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 43 UK Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 44 France Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 45 Italy Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 46 Spain Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 47 Russia Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 48 Rest of Europe Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 49 Asia Pacific Drug Discovery Outsourcing Market Forecast by Country, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 50 Asia Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 51 Asia Pacific Drug Discovery Outsourcing Market Forecast by Workflow, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 52 Asia Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 53 Asia Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 54 Asia Pacific Drug Discovery Outsourcing Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 55 Japan Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 56 India Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 57 Australia Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 58 South Korea Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 59 South-East Asia Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 60 Rest of Asia Pacific Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 61 Latin America Drug Discovery Outsourcing Market Forecast by Country, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 62 Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 63 Latin America Drug Discovery Outsourcing Market Forecast by Workflow, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 64 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 65 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 66 Latin America Drug Discovery Outsourcing Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 67 Brazil Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 68 Mexico Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 69 Argentina Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 70 Colombia Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 71 Rest of Latin America Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 72 MEA Drug Discovery Outsourcing Market Forecast by Country, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 73 MEA Drug Discovery Outsourcing Market Forecast by Service Type, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 74 MEA Drug Discovery Outsourcing Market Forecast by Workflow, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 75 MEA Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 76 MEA Drug Discovery Outsourcing Market Forecast by Molecule Type, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 77 MEA Drug Discovery Outsourcing Market Forecast by End-users, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 78 GCC Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 79 South Africa Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 80 Rest of MEA Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR%, CAGR%)
Table 81 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 Curia Global, Inc.: Service Benchmarking
Table 83 Curia Global, Inc.: Strategic Outlook
Table 84 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Charles River Laboratories: Service Benchmarking
Table 86 Charles River Laboratories: Strategic Outlook
Table 87 Dalton Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Dalton Pharma: Service Benchmarking
Table 89 Dalton Pharma: Strategic Outlook
Table 90 Domainex: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Domainex: Service Benchmarking
Table 92 Domainex: Strategic Outlook
Table 93 Eurofins: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 Eurofins: Service Benchmarking
Table 95 Eurofins: Strategic Outlook
Table 96 Evotec AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Evotec AG: Service Benchmarking
Table 98 Evotec AG: Strategic Outlook
Table 99 Genscript: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 Genscript: Service Benchmarking
Table 101 Genscript: Strategic Outlook
Table 102 Aragen Life Sciences Pvt. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 Aragen Life Sciences Pvt. Ltd.: Service Benchmarking
Table 104 Aragen Life Sciences Pvt. Ltd.: Strategic Outlook
Table 105 Jubilant Biosys Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 Jubilant Biosys Ltd.: Service Benchmarking
Table 107 Laboratory Corporation of America Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Laboratory Corporation of America Holdings: Service Benchmarking
Table 109 Laboratory Corporation of America Holdings: Strategic Outlook
Table 110 Pharmaron: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Pharmaron: Service Benchmarking
Table 112 Pharmaron: Strategic Outlook
Table 113 QIAGEN N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 QIAGEN N.V.: Service Benchmarking
Table 115 QIAGEN N.V.: Strategic Outlook
Table 116 Selvita: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 117 Selvita: Service Benchmarking
Table 118 Selvita: Strategic Outlook
Table 119 BioDuro: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 120 BioDuro: Service Benchmarking
Table 121 Sygnature Discovery: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Sygnature Discovery: Service Benchmarking
Table 123 Sygnature Discovery: Strategic Outlook
Table 124 Syngene International: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 125 Syngene International: Service Benchmarking
Table 126 Syngene International: Strategic Outlook
Table 127 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 128 Thermo Fisher Scientific Inc.: Service Benchmarking
Table 129 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 130 WuXi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 131 WuXi AppTec: Service Benchmarking
Table 132 WuXi AppTec.: Strategic Outlook
Table 133 Oncodesign: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 134 Oncodesign: Service Benchmarking
Table 135 Oncodesign.: Strategic Outlook
Table 136 Novalix: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 137 Novalix: Service Benchmarking
Table 138 Novalix.: Strategic Outlook
Table 139 Celonic Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 Celonic Group: Service Benchmarking
?

List of Figures
Figure 1 Drug Discovery Outsourcing Market Segmentation
Figure 2 Drug Discovery Outsourcing Market by Service Type: Market Attractiveness Index
Figure 3 Drug Discovery Outsourcing Market by Workflow: Market Attractiveness Index
Figure 4 Drug Discovery Outsourcing Market by Therapeutic Area: Market Attractiveness Index
Figure 5 Drug Discovery Outsourcing Market by Molecule Type: Market Attractiveness Index
Figure 6 Drug Discovery Outsourcing Market by End-users: Market Attractiveness Index
Figure 7 Drug Discovery Outsourcing Market Attractiveness Index by Region
Figure 8 Drug Discovery Outsourcing Market: Market Dynamics
Figure 9 Drug Discovery Outsourcing Market: Impact Analysis
Figure 10 Drug Discovery Outsourcing Market: Porter’s Five Forces Analysis
Figure 11 Drug Discovery Outsourcing Market Attractiveness Index by Service Type
Figure 12 Drug Discovery Outsourcing Market Forecast by Service Type, 2025-2035 (US$ Million, AGR %)
Figure 13 Drug Discovery Outsourcing Market Share Forecast by Service Type, 2025, 2030, 2035 (%)
Figure 14 Chemistry Services Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 15 Chemistry Services Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 16 Biology Services Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 17 Biology Services Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 18 Drug Discovery Outsourcing Market Attractiveness Index by Service Type
Figure 19 Drug Discovery Outsourcing Market Forecast by Workflow, 2025-2035 (US$ Million, AGR %)
Figure 20 Drug Discovery Outsourcing Market Share Forecast by Workflow, 2025, 2030, 2035 (%)
Figure 21 Target Identification & Screening Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 22 Target Identification & Screening Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 23 Target Validation & Functional Informatics Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 24 Target Validation & Functional Informatics Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 25 Lead Identification & Candidate Optimization Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 26 Lead Identification & Candidate Optimization Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 27 Preclinical Development Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 28 Preclinical Development Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 29 Other Associated Workflow Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 30 Other Associated Workflow Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 31 Drug Discovery Outsourcing Market Attractiveness Index by Therapeutic Area
Figure 32 Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2025, 2030, 2035 (%)
Figure 33 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 34 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 35 Infectious Disease Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 36 Infectious Disease Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 37 Central Nervous System Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 38 Central Nervous System Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 39 Immunology Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 40 Immunology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 41 Cardiovascular Disease Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 42 Cardiovascular Disease Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 43 Metabolic Disease Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 44 Metabolic Disease Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 45 Respiratory Disease Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 46 Respiratory Disease Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 47 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 48 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 49 Drug Discovery Outsourcing Market Attractiveness Index by Molecule Type
Figure 50 Drug Discovery Outsourcing Market Forecast by Molecule Type, 2025-2035 (US$ Million, AGR %)
Figure 51 Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2025, 2030, 2035 (%)
Figure 52 Large Molecules Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 53 Large Molecules Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 54 Small Molecules Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 55 Small Molecules Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 56 Drug Discovery Outsourcing Market Attractiveness Index by End-users
Figure 57 Drug Discovery Outsourcing Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 58 Drug Discovery Outsourcing Market Share Forecast by End-users, 2025, 2030, 2035 (%)
Figure 59 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 60 Pharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 61 Academic Institutes Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 62 Academic Institutes Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 63 Others Segment Market Forecast by Region, 2025-2035 (US$ Million, AGR %)
Figure 64 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 65 Drug Discovery Outsourcing Market Forecast by Region 2025, 2030, 2035 (Revenue, CAGR%)
Figure 66 Drug Discovery Outsourcing Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 67 Drug Discovery Outsourcing Market by Region, 2025-2035 (US$ Mn)
Figure 68 North America Drug Discovery Outsourcing Market Attractiveness Index
Figure 69 North America Drug Discovery Outsourcing Market by Country, 2025, 2030& 2035 (US$ million)
Figure 70 North America Drug Discovery Outsourcing Market Forecast by Country, 2025-2035 (US$ million)
Figure 71 North America Drug Discovery Outsourcing Market Share Forecast by Country, 2025 & 2035 (%)
Figure 72 North America Drug Discovery Outsourcing Market Forecast by Service Type, 2025-2035 (US$ Million, AGR %)
Figure 73 North America Drug Discovery Outsourcing Market Share Forecast by Service Type, 2025 & 2035 (%)
Figure 74 North America Drug Discovery Outsourcing Market Forecast by Workflow, 2025-2035 (US$ Million, AGR %)
Figure 75 North America Drug Discovery Outsourcing Market Share Forecast by Workflow, 2025 & 2035 (%)
Figure 76 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
Figure 77 North America Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
Figure 78 North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2025-2035 (US$ Million, AGR %)
Figure 79 North America Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2025 & 2035 (%)
Figure 80 North America Drug Discovery Outsourcing Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 81 North America Drug Discovery Outsourcing Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 82 U.S. Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 83 Canada Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 84 Europe Drug Discovery Outsourcing Market Attractiveness Index
Figure 85 Europe Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 86 Europe Drug Discovery Outsourcing Market Forecast by Country, 2025-2035 (US$ million)
Figure 87 Europe Drug Discovery Outsourcing Market Share Forecast by Country, 2025 & 2035 (%)
Figure 88 Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2025-2035 (US$ Million, AGR %)
Figure 89 Europe Drug Discovery Outsourcing Market Share Forecast by Service Type, 2025 & 2035 (%)
Figure 90 Europe Drug Discovery Outsourcing Market Forecast by Workflow, 2025-2035 (US$ Million, AGR %)
Figure 91 Europe Drug Discovery Outsourcing Market Share Forecast by Workflow, 2025 & 2035 (%)
Figure 92 Europe Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
Figure 93 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2025-2035 (US$ Million, AGR %)
Figure 94 Europe Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2025 & 2035 (%)
Figure 95 Europe Drug Discovery Outsourcing Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 96 Europe Drug Discovery Outsourcing Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 97 Germany Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 98 UK Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 99 France Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 100 Italy Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 101 Spain Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 102 Russia Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 103 Rest of Europe Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 104 Asia Pacific Drug Discovery Outsourcing Market Attractiveness Index
Figure 105 Asia Pacific Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 106 Asia Pacific Drug Discovery Outsourcing Market Forecast by Country, 2025-2035 (US$ Million)
Figure 107 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Country, 2025 & 2035 (%)
Figure 108 Asia Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2025-2035 (US$ Million, AGR %)
Figure 109 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Service Type, 2025 & 2035 (%)
Figure 110 Asia Pacific Drug Discovery Outsourcing Market Forecast by Workflow, 2025-2035 (US$ Million, AGR %)
Figure 111 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Workflow, 2025 & 2035 (%)
Figure 112 Asia Pacific Drug Discovery Outsourcing Market Forecast by Workflow, 2025-2035 (US$ Million, AGR %)
Figure 113 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
Figure 114 Asia Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2025-2035 (US$ Million, AGR %)
Figure 115 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2025 & 2035 (%)
Figure 116 Asia Pacific Drug Discovery Outsourcing Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 117 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 118 Japan Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 119 China Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 120 India Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 121 Australia Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 122 South Korea Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 123 South-East Asia Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 124 Rest of Asia Pacific Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 125 Latin America Drug Discovery Outsourcing Market Attractiveness Index
Figure 126 Latin America Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ Million)
Figure 127 Latin America Drug Discovery Outsourcing Market Forecast by Country, 2025-2035 (US$ Million)
Figure 128 Latin America Drug Discovery Outsourcing Market Share Forecast by Country, 2025 & 2035 (%)
Figure 129 Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2025-2035 (US$ Million, AGR %)
Figure 130 Latin America Drug Discovery Outsourcing Market Share Forecast by Service Type, 2025 & 2035 (%)
Figure 131 Latin America Drug Discovery Outsourcing Market Forecast by Workflow, 2025-2035 (US$ Million, AGR %)
Figure 132 Latin America Drug Discovery Outsourcing Market Share Forecast by Workflow, 2025 & 2035 (%)
Figure 133 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
Figure 134 Latin America Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
Figure 135 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2025-2035 (US$ Million, AGR %)
Figure 136 Latin America Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2025 & 2035 (%)
Figure 137 Latin America Drug Discovery Outsourcing Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 138 Latin America Drug Discovery Outsourcing Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 139 Brazil Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 140 Mexico Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 141 Argentina Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 142 Colombia Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 143 Rest of Latin America Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 144 MEA Drug Discovery Outsourcing Market Attractiveness Index
Figure 145 MEA Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ Million)
Figure 146 MEA Drug Discovery Outsourcing Market Forecast by Country, 2025-2035 (US$ Million)
Figure 147 MEA Drug Discovery Outsourcing Market Share Forecast by Country, 2025 & 2035 (%)
Figure 148 MEA Drug Discovery Outsourcing Market Forecast by Service Type, 2025-2035 (US$ Million, AGR %)
Figure 149 MEA Drug Discovery Outsourcing Market Share Forecast by Service Type, 2025 & 2035 (%)
Figure 150 MEA Drug Discovery Outsourcing Market Forecast by Workflow, 2025-2035 (US$ Million, AGR %)
Figure 151 MEA Drug Discovery Outsourcing Market Share Forecast by Workflow, 2025 & 2035 (%)
Figure 152 MEA Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2025-2035 (US$ Million, AGR %)
Figure 153 MEA Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2025 & 2035 (%)
Figure 154 MEA Drug Discovery Outsourcing Market Forecast by Molecule Type, 2025-2035 (US$ Million, AGR %)
Figure 155 MEA Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2025 & 2035 (%)
Figure 156 MEA Drug Discovery Outsourcing Market Forecast by End-users, 2025-2035 (US$ Million, AGR %)
Figure 157 MEA Drug Discovery Outsourcing Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 158 GCC Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 159 South Africa Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 160 Rest of MEA Drug Discovery Outsourcing Market Forecast, 2025-2035 (US$ Million, AGR %)
Figure 161 Charles River Laboratories: Net Revenue, 2019-2024 (US$ Million, AGR %)
Figure 162 Charles River Laboratories: Regional Market Shares (%), 2023
Figure 163 Charles River Laboratories: Business Segment Market Shares (%), 2023
Figure 164 Eurofins: Net Revenue, 2019-2024 (US$ million, AGR%)
Figure 165 Eurofins: Regional Market Share, 2024 (%)
Figure 166 Evotec AG: Net Revenue, 2019-2023 (US$ million, AGR%)
Figure 167 Evotec AG: Regional Market Share, 2023 (%)
Figure 168 Evotec AG: R&D, 2019-2023 (US$ million, AGR%)
Figure 169 Laboratory Corporation of America Holdings: Net Revenue, 2019-2024 (US$ million, AGR%)
Figure 170 Laboratory Corporation of America Holdings: Business Segment Market Shares (%), 2023
Figure 171 Pharmaron: Net Revenue, 2019-2023 (US$ million, AGR%)
Figure 172 QIAGEN N.V.: Net Revenue, 2019-2024 (US$ million, AGR%)
Figure 173 QIAGEN N.V.: R&D, 2019-2024 (US$ million, AGR%)
Figure 174 Syngene International: Net Revenue, 2019-2024 (US$ million, AGR%)
Figure 175 Syngene International: Regional Market Share, 2024 (%)
Figure 176 Thermo Fisher Scientific Inc.: Net Revenue, 2019-2024 (US$ Million, AGR %)
Figure 177 Thermo Fisher Scientific Inc.: R&D, 2019-2024 (US$ Million, AGR %)
Figure 178 Thermo Fisher Scientific Inc.: Regional Market Shares (%), 2023
Figure 179 Thermo Fisher Scientific Inc.: Business Segment Market Shares (%), 2023
Figure 180 WuXi AppTec: Net Revenue, 2019-2024 (US$ Million, AGR %)
Figure 181 WuXi AppTec: Regional Market Shares (%), 2024
Figure 182 WuXi AppTec: Business Segment Market Shares (%), 2024